A New Antibody Binding Test for Potency Assessment of the Human Rabies Vaccine.


Journal

Viral immunology
ISSN: 1557-8976
Titre abrégé: Viral Immunol
Pays: United States
ID NLM: 8801552

Informations de publication

Date de publication:
03 2023
Historique:
pubmed: 25 2 2023
medline: 17 3 2023
entrez: 24 2 2023
Statut: ppublish

Résumé

This study established a new protocol of the antibody binding test to evaluate the potency of the rabies vaccine containing the final bulk and the product. The principle of this experiment is to combine rabies vaccine with quantitative anti-rabies virus neutralizing antibody. After combination, the remaining rabies vaccine is combined with the quantitative fluorescent labeled rabies virus. After this, observe the remaining fluorescent labeled rabies virus, calculate the fluorescence area with fluorescence observation equipment, then calculate the potency of rabies vaccine by Reed and Muench method. The test results of many batches of rabies vaccine final bulk and finished products showed that the potency detected by this method was consistent with that of National Institute of Health method.

Identifiants

pubmed: 36827324
doi: 10.1089/vim.2022.0161
doi:

Substances chimiques

Antibodies, Viral 0
Rabies Vaccines 0
Antibodies, Neutralizing 0
Antibodies, Monoclonal 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-126

Auteurs

Li Miao (L)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Xiaoli Wang (X)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Chengshuang Zhao (C)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Yanyu Li (Y)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Wei He (W)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Yue Li (Y)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Jingzhi Zhang (J)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Xiuzhi Xu (X)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Xingfu Feng (X)

Department of Vaccine Research, Changchun Zhuoyi Biological Co., Ltd., Changchun, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH